Skip to content

Pre-Surgical Grading System of Asherman Syndrome

Asherman Syndrome: Pre-surgical Grading to Improve Gauge Prognostic Values and Improve Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05901948
Enrollment
65
Registered
2023-06-13
Start date
2020-01-07
Completion date
2023-03-15
Last updated
2023-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asherman Syndrome

Keywords

Asherman Syndrome, Hysteroscopy, Intra-Uterine Surgery, Intra-Uterine Adhesions, Classification

Brief summary

Utilising a novel pre-surgical grading system to class cases of asherman syndrome into 3 groups based on expected difficulty of surgery and potential prognostic outcomes.

Detailed description

Using the grading system, patients are classified into Mild, Moderate and Severe Asherman Syndrome. With the mild disease having the best prognostic value and a 1 step procedure, Moderate cases having a mediocre prognosis and usually multi-step procedure and Severe cases having a poor prognosis and counseled to other options. This observational study looks at the surgical outcomes following hysteroscopy for cases graded according to the new system to identify the accuracy of the classification in predicting the surgical success and prognostic value.

Interventions

Novel Asherman Scoring Classification

Sponsors

Ebtesama Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Asherman Syndrome * intra-uterine synechiae

Exclusion criteria

* patients with a fundectomy or uterine reduction surgery.

Design outcomes

Primary

MeasureTime frameDescription
Percentage Resumption of normal cavity on hystero-salpingography1 monthassessing the improvement of the cavity of the uterus in hystero-salpingography

Secondary

MeasureTime frameDescription
Menses3 monthsImprovement in patients menstrual cycle

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026